REAL-WORLD COST OF TREATING INADEQUATE RESPONDERS TO ANTI-TUMOUR NECROSIS FACTOR THERAPY

被引：0
|
作者：
Thomson, E. [1 ]
Nadkarni, A. [2 ]
Brouillette, M. [1 ]
Johnston, S. [1 ]
机构：
[1] Truven Hlth Analyt, Bethesda, MD USA
[2] Bristol Myers Squibb, Plainsboro, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.1737
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0414
引用
收藏
页码：1032 / 1032
页数：1
相关论文
共 50 条
  • [31] Anti-tumour necrosis factor therapy for ulcerative colitis - Evidence to date
    Thukral, Chandrashekhar
    Cheifetz, Adam
    Peppercorn, Mark A.
    DRUGS, 2006, 66 (16) : 2059 - 2065
  • [32] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Papamichael, Konstantinos
    Vermeire, Severine
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (16) : 4773 - 4778
  • [33] Serious infection in patients with Crohn's disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world study
    Afzali, A.
    Song, X.
    Shi, N.
    Skup, M.
    Lee, W. -J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S226 - S226
  • [34] Anti-tumour necrosis factor therapy is a risk factor for certain subtypes of chronic rhinosinusitis
    Leonard, C. G.
    Masih, C.
    McDonald, S.
    Taylor, G.
    Maiden, N.
    Leyden, P. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S148 - S148
  • [35] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    RHEUMATOLOGY, 2016, 55 : 105 - 105
  • [36] Long term treatment with tofacitinib for ulcerative colitis refractory to anti-tumour necrosis factor agents: real-world experience from a single centre
    El Atrash, Malik Satea
    Ahmed, Omar
    Hamdy, Mohamed Yehia
    Brooks, Alenka J.
    Chew, Thean S.
    Phillips, Anne
    Rej, Anupam
    Robinson, Kerry
    Lobo, Alan J.
    Hale, Melissa F.
    GUT, 2023, 72 (SUPPL_2) : A107 - A108
  • [37] Anti-tumour necrosis factor therapy is associated with certain subtypes of chronic rhinosinusitis
    Leonard, C. G.
    Masih, C.
    McDonald, S.
    Taylor, G.
    Maiden, N.
    Leyden, P. J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (06) : 560 - 564
  • [38] Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy
    Pamela Mangat
    Samuel Whittle
    Les Cleland
    Vidya Limaye
    Clinical Rheumatology, 2008, 27 : 1593 - 1595
  • [39] Detecting Latent Tuberculosis Infection during Anti-Tumour Necrosis Factor Therapy
    Ringrose, Jennifer
    Taylor-Gjevre, Regina
    Sanche, Stephen
    Hoeppner, Vernon
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1151 - 1151
  • [40] Lupus-like syndrome associated with anti-tumour necrosis factorα therapy
    Sun, S
    Martin, L
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1884 - 1884
12345